Global /Taiwan /Healthcare /Medical Devices /4186

Taiwan Advance Bio-Pharmaceutical Inc.

4186

• TPEX: 4186 • Delayed

11.30TWD -1.3%

0.3592 USD

As of 5 June 2026, Taiwan Advance Bio-Pharmaceutical Inc. has a market cap of $32.76M USD, ranking #33653 globally and #2074 in Taiwan. It ranks #3042 in the Healthcare sector, and #641 in the Medical Devices industry.

Global Rank

33653

Country Rank

2074

Sector Rank

3042

Industry Rank

641

Key Stats

Market Cap

$32.76MUSD

1.03B TWD

Enterprise Value

$37.26MUSD

1.17B TWD

Revenue (TTM)

$11.82MUSD

371.86M TWD

EBITDA (TTM)

$1.86MUSD

58.38M TWD

Net Income (TTM)

$743.75KUSD

23.4M TWD

EBITDA Margin

16%

Profit Margin

6.3%

PE Ratio

44.8

PS Ratio

2.8

PB Ratio

4.1

EV/EBITDA

18.3

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

Wen-Long Su open_in_new

Employees

165

Founded

1989

Website

biotest.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	-7.7%	12%	-2.1%	-13%	2.7%	-25%	-42%	-49%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	4186 台灣尖端先進生技醫藥股份有限公司 ISIN: TW0004186002 Shares Out.: Shares Outstanding: 90.0M¹ Shares Float: 68.113M² TV: TradingView: TPEX: 4186 SA: Stock Analysis: TPEX: 4186 YF: Yahoo Finance: 4186.TWO GF: Google Finance: TPEX: 4186 BA: Barron's: 4186 MS: Morningstar: ROCO: 4186	11.30 TWD	TV: TradingView: TPEX: 4186 SA: Stock Analysis: TPEX: 4186 YF: Yahoo Finance: 4186.TWO GF: Google Finance: TPEX: 4186 BA: Barron's: 4186 MS: Morningstar: ROCO: 4186

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in Taipei, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$670.9M 21.1B TWD 2K%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$378.99M 11.92B TWD 1K%	8.3	Taiwan
YD Bio Ltd. NASDAQ: YDES	$364.92M 1K%	-	Taiwan
United Orthopedic Corp. TPEX: 4129	$303.5M 9.55B TWD 826%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$255.54M 8.04B TWD 680%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$191.77M 6.03B TWD 485%	16.4	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 529K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 491K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 485K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 386K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 368K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 311K%	22.2	Ireland

chevron_leftBack